Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Merrimack Pharmaceuticals Inc. (MACK)
NASDAQ:MACK
Holding MACK?
Track your performance easily
MACK Stock Chart & Stats
Day’s Range$15.13 - $15.17
52-Week Range― - ―
Previous Close$15.13
Volume1.26M
Average Volume (3M)N/A
Market Cap
$223.75M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Merrimack Pharmaceuticals News
PremiumCompany Announcements
Merrimack Pharmaceuticals Approves Liquidation and Dividend
PremiumCompany Announcements
Merrimack Pharmaceuticals Plans Liquidating Dividend
PremiumCompany Announcements
Merrimack Pharmaceuticals Announces Nasdaq Delisting and Liquidation Plan
PremiumCompany Announcements
Merrimack’s FDA Approval Milestone and Scheduled Dissolution Vote
PremiumCompany Announcements
Merrimack Pharmaceuticals Proposes Liquidation PlanRisk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MACK FAQ
What was Merrimack Pharmaceuticals Inc.’s price range in the past 12 months?
Currently, no data Available
What is Merrimack Pharmaceuticals Inc.’s market cap?
Currently, no data Available
When is Merrimack Pharmaceuticals Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Merrimack Pharmaceuticals Inc.’s earnings last quarter?
Currently, no data Available
Is Merrimack Pharmaceuticals Inc. overvalued?
According to Wall Street analysts Merrimack Pharmaceuticals Inc.’s price is currently Overvalued.
Does Merrimack Pharmaceuticals Inc. pay dividends?
Merrimack Pharmaceuticals Inc. does not currently pay dividends.
What is Merrimack Pharmaceuticals Inc.’s EPS estimate?
Merrimack Pharmaceuticals Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Merrimack Pharmaceuticals Inc. have?
Currently, no data Available
What happened to Merrimack Pharmaceuticals Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Merrimack Pharmaceuticals Inc.?
Among the largest hedge funds holding Merrimack Pharmaceuticals Inc.’s share is Western Standard Llc. It holds Merrimack Pharmaceuticals Inc.’s shares valued at 32M.
---
Merrimack Pharmaceuticals Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
60420.00%
12-Months-Change
Fundamentals
Return on Equity
-1.12%
Trailing 12-Months
Asset Growth
1144.32%
Trailing 12-Months
Company Description
Merrimack Pharmaceuticals Inc.
Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA.
---
Technical Analysis
---